NIOSH Pocket Guide to Chemical Hazards

Coal tar pitch volatiles CAS 65996-93-2

RTECS GF8655000
Synonyms & Trade Names
Synonyms vary depending upon the specific compound (e.g., pyrene, phenanthrene, acridine, chrysene, anthracene & benzo(a)pyrene). [Note: NIOSH considers coal tar, coal tar pitch, and creosote to be coal tar products.]
DOT ID & Guide
Exposure
Limits
NIOSH REL: Ca TWA 0.1 mg/m3 (cyclohexane-extractable fraction) See Appendix A See Appendix C
OSHA PEL: TWA 0.2 mg/m3 (benzene-soluble fraction) [1910.1002] See Appendix C
IDLH Ca [80 mg/m3] Conversion
Physical Description
Black or dark-brown amorphous residue.
Properties vary depending upon the specific compound.











Combustible Solids
Incompatibilities & Reactivities
Strong oxidizers
Measurement Methods
OSHA 58
Personal Protection & Sanitation
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: Daily
Remove: No recommendation
Change: Daily

First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
Respirator Recommendations NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus
Exposure Routes inhalation, skin and/or eye contact
Symptoms Dermatitis, bronchitis, [potential occupational carcinogen]
Target Organs respiratory system, skin, bladder, kidneys

Cancer Site [lung, kidney & skin cancer]
See also: INTRODUCTION